Quantcast

Latest immunotherapies Stories

2015-02-17 08:35:25

ALBUQUERQUE, N.M., Feb. 17, 2015 /PRNewswire/ -- Agilvax, Inc.

2015-01-29 08:32:50

Dr. Gelder's Accomplishments Include Successful Development of Cancer Therapies at Pfizer, Wyeth and Bayer PLYMOUTH MEETING, Pa., Jan.

2015-01-16 12:23:50

Initiation of Registrational Studies Planned for This Year MORRISTOWN, N.J., Jan.

2015-01-06 08:32:02

Lead Immunotherapy Product Candidate GEN-1 to Enter Dose Escalating Clinical Study in the Second Half of 2015 LAWRENCEVILLE, N.J., Jan.

2015-01-05 12:23:52

ORLANDO, Fla., Jan. 5, 2015 /PRNewswire/ -- Immune Therapeutics Inc.

2014-12-10 04:21:02

SCIB1 continues to generate highly encouraging survival data; Modi-1 vaccine on track for 2016 entry into clinic NOTTINGHAM, England, December 10, 2014 /PRNewswire/ --

2014-11-05 08:35:04

Invetech to supply automated production systems for commercialization of patient-specific immunotherapies based on Argos' proprietary Arcelis® technology platform. SAN DIEGO and DURHAM,

2014-10-22 04:22:27

PhosImmune and PureMHC Working Together On Immunotherapies for Cancer CHARLOTTESVILLE, Va. and AUSTIN, Texas, Oct. 22, 2014 /PRNewswire/ -- PhosImmune Inc.


Word of the Day
marcescent
  • Withering but not falling off, as a blossom that persists on a twig after flowering.
The word 'marcescent' comes from a Latin word meaning 'to wither'.
Related